KIEFFER TARA LYNN (Sr. VP, New Product Dev.) sold 6.4% of their position (2.11K shares) of ENANTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $30.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/5/2025ACC: 0002064832-25-000061
Officer· Sr. VP, New Product Dev.
Since Dec 2020
-2.11K
Net shares
Net seller
$30.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.11K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.11K
Price / share
$14.23
Trade value
$29.97K
% of position
6.4%
12/5/2025
32.73K→30.62K
Total
Net shares
−2.11K
Net value
-$29.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | S · Sale | −2.11K | $14.23 | $29.97K | 6.4% | 32.73K | 30.62K |
| Total | −2.11K | -$29.97K | ||||||
Derivative Transactions0
No derivative transactions reported